Osteologie, Table of Contents Osteologie 2020; 29(03): 240-241DOI: 10.1055/a-1207-1508 Osteoporose-Update Osteoporose in Zeiten der COVID-19-Pandemie Michael Pfeifer Recommend Article Abstract Buy Article Full Text References Literatur 1 World Health Organization. Coronavirus disease (COVID-19) situation report – 125. https/www.who.int/docs/default-source/coronavirus/situation-reports/20200524-covid-19-sitrep-125 . WHO 2020 2 Yu EW, Tsourdi E, Clarke BL. et al. Osteoporosis management in the era of COVID-19. J Bone Miner Res 2020; 35 (06) : 1009-1013 . DOI 10.1002/jbmr.4049 3 Napoli N, Elderkin AL, Kiel DP, Khosla S. Comment: managing fragility fractures during the COVID-19 pandemic. Nature reviews endocrinology. https://doi.org/10.1038/s41574-020-0379-z 4 https://www.robert-koch-institut.de Zugriff am 06.07.2020 5 Böhmer MM, Buchholz U, Corman VM. et al. Investigation of a COVID-19 outbreak in Germany resulting from a single travel-associated primary case: A case series. Lancet Infect Dis 2020 published online May 15, 2020. https://doi.org/10.1016/s1473-3099(20)30314-5 6 Zhu N, Zhang D, Wang W. et al. A novel coronavirus from patients with pneumonia in China. N Engl J Med 2020; 382: 727-733 7 Conley RB, Adib G, Adler RA. et al. Secondary Fracture Prevention: Consensus Clinical Recommendations from a Multistakeholder Coalition. J Bone Miner Res. 2020; 35: 36-52 . doi: 10.1002/jbmr.3877 8 https://www.dv-osteologie.de/leitlinien 9 Ebeling PR, Adler RA, Jones G. et al. Management of endocrine disease: Therapeutics of Vitamin D. Eur J Endocrinol. 2018; 179: R239-R259 . Published 2018 Oct 12. doi: 10.1530/EJE-18-0151 In der Rubrik „Osteoporose Update“ referiert und kommentiert Dr. Michael Pfeifer, DVO Leitliniengruppe Osteoporose, für Sie die aktuelle internationale Literatur.
